Kumar Neil

Chief Executive Officer | CEO And President | See Remarks

1 company

Weak

Trades Analyzed

12M Win Rate

11.1%

Avg 3M Return

-25.9%

Avg 12M Return

-84.4%

Kumar Neil is a Chief Executive Officer at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 0 buys and 75 sells.

Estimated insider holdings value: $39.7M based on current market prices.

Holdings by Company

BBIOApr 10, 2026

Current Shares595.7K

Value$39.73M

Net Activity-3,688,894

Bought: 0Sold: 3.69M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 10, 2026	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$74.61	$5,968,780.10	-0.4%	-	-
Jan 9, 2026	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$75.54	$6,043,168.23	-0.2%	-2.2%	-
Dec 15, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sale+OE	30,011	$74.64	$2,239,902.15	-6.1%	-4.7%	-
Dec 5, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$73.86	$5,908,475.89	-0.3%	-10.0%	-
Nov 20, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	26,156	$65.84	$1,722,223.69	-3.5%	+14.4%	-
Nov 7, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$62.29	$4,983,111.08	-0.2%	+3.1%	-
Oct 9, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$54.79	$4,383,442.21	-0.6%	+35.6%	-
Sep 5, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$52.20	$4,175,835.24	-0.3%	+40.1%	-
Aug 20, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	26,156	$48.82	$1,276,927.17	-5.5%	+34.2%	-
Aug 8, 2025	BBIO Bridgebio Pharma, Inc.	Chief Executive Officer	Sell	80,000	$45.84	$3,666,949.26	-0.4%	+34.7%	-